Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel aldose reductase inhibitor for diabetic neuropathy characterized at ACS meeting

April 10, 2002

Potent, selective, nonpeptide PTP1B inhibitors discovered in Novo Nordisk/Ontogen joint effort

April 9, 2002

ACS news: Abbott describes discovery of new series of PTP1B inhibitors

April 9, 2002

Japan Tobacco reveals new series that stimulates apo A-I production

April 8, 2002

Avidex licenses CD80 antagonists from Active Biotech

April 8, 2002

New use for Cozaar to be reviewed this week by advisory committee

April 8, 2002

Treatment initiated in at-home phase II/III trial of Alista for FSAD

April 5, 2002

Heterocyclic compounds useful in obesity and diabetes according to Shionogi patent

April 5, 2002

Novel antidiabetic tetrazolylphenylacetamides described in recent patent

April 5, 2002

Roche patent covers new inhibitors of lanosterol synthase and their potential uses

April 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...